Nerys Avery News Today

China's aging population is proving an opportunity for some Swiss healthcare providers.

Turkey and Novartis are in a stand-off over approval of Zolgensma - a $2.1 million gene therapy.

Swiss pharma giant Novartis launched Zolgensma five years ago with a price tag of $2.1 million. What happened to it?

As more multi-million-dollar drugs come on the market, there are growing calls for transparency on drug pricing.

As more multi-million-dollar drugs come on the market, there are growing calls for transparency on drug pricing.

How can populations in sanctioned countries have access to medicine? There are no easy answers.

As the use of sanctions has exploded over the past few years, concerns are growing about the human suffering they cause.

Growing and exporting cocoa beans may be big business but it’s low-margin and volatile. Moving up the value chain could be more profitable and stable.

Ghana and Ivory Coast tried to raise cocoa bean prices but were derailed by the Covid-19 pandemic. They’re now trying to claw back lost ground.

Pharma companies are close to a cure for cancer, but will the hefty price tags make treatments unaffordable for most of the world?